Results 251 to 259 of about 35,970 (259)

Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series

Annals of the Rheumatic Diseases, 2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recently discovered coronavirus, is responsible for COVID-19, a newly emerged disease that has become pandemic.
A. Aouba, A. Baldolli, L. Geffray, R. Verdon, E. Bergot, N. Martin-Silva, A. Justet   +6 more
semanticscholar   +1 more source

The clinical role of anakinra in the armamentarium against familial Mediterranean fever

Expert Review of Clinical Immunology, 2023
Introduction Familial Mediterranean Fever (FMF) is the most common autoinflammatory disease that has mainly been treated with colchicine since 1972. A significant portion of patients do not respond to colchicine and require further treatment, mainly IL ...
K. Parlar, M. Ates, B. Egeli, S. Uğurlu
semanticscholar   +1 more source

Repurposing Anakinra for Alzheimer's Disease: The In Vitro and In Vivo Effects of Anakinra on LPS- and AC-Induced Neuroinflammation.

ACS Chemical Neuroscience
Alzheimer's disease is a significant global health issue, and studies suggest that neuroinflammation plays a vital role in the advancement of this disease.
Thaarvena Retinasamy, Amber Lot Yee Lee, Hsien Siang Lee, V. Lee, Mohd Farooq Shaikh, K. Y. Yeong   +5 more
semanticscholar   +1 more source

CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results

Nature Network Boston, 2023
Jae H. Park, Karthik D Nath, S. Devlin, C. Sauter, M. Palomba, G. Shah, P. Dahi, R. Lin, M. Scordo, M. Perales, R. Shouval, A. A. Tomas, E. Cathcart, E. Mead, B. Santomasso, A. Holodny, R. Brentjens, I. Rivière, M. Sadelain   +18 more
semanticscholar   +1 more source

Anakinra for refractory CRS or ICANS after CAR T-cell therapy.

Transplantation and Cellular Therapy, 2023
Nicolas Gazeau, Emily C. Liang, Q. Wu, Jenna M Voutsinas, P. Barba, G. Iacoboni, M. Kwon, J. L. R. Ortega, L. López-Corral, R. Hernani, V. Ortiz-Maldonado, N. Martínez-Cibrian, Antonio Pérez Martínez, R. Maziarz, S. Williamson, Eneida R. Nemecek, M. Shadman, A. Cowan, D. Green, E. Kimble, A. Hirayama, D. Maloney, C. Turtle, J. Gauthier   +23 more
semanticscholar   +1 more source

Rasmussen’s syndrome treated with anakinra

Journal of Neurology, 2023
Abdullah Arcan, Esra Koçhan Kızılkılıç, Ayşegül Gündüz, Rumeysa Unkun, A. Vezzani, Ç. Özkara   +5 more
semanticscholar   +1 more source

The efficacy of a single-dose anakinra injection during disease attack in pediatric familial Mediterranean fever

Rheumatology International, 2023
Sinem Oral Cebeci, Mehmet Yıldız, Aybuke Gunalp, M. N. Cebi, Berivan Kilinc, Eymen Pınar, Elif Kılıç Konte, E. Aslan, Fatih Haşlak, Amra Adrovic, S. Şahin, K. Barut, O. Kasapcopur   +12 more
semanticscholar   +1 more source

A single-centre retrospective case series of Anakinra for incident calcium pyrophosphate deposition disease

Clinical Rheumatology, 2023
Alwin Lian, Apoorva Shandilya, J. Riordan   +2 more
semanticscholar   +1 more source

Effectiveness and safety of IL1 inhibition with anakinra in chronic refractory idiopathic myocarditis

Internal and Emergency Medicine, 2023
Danilo Malandrino, Federica Bello, G. Lopalco, L. Cantarini, I. Olivotto, G. Emmi, Domenico Prisco   +6 more
semanticscholar   +1 more source